Literature DB >> 18465366

The morphology and syntax of individuals who use AAC: research review and implications for effective practice.

Cathy Binger1, Janice Light.   

Abstract

A research review of 31 studies pertaining to the morphology and syntax of individuals who use augmentative and alternative communication (AAC) and who had severe speech and physical impairments (SSPI) was completed. Results suggest that, although many individuals who use AAC exhibit comprehension and expression of a wide range of grammatical structures, these individuals are at risk for experiencing grammar deficits. A wide range of individual differences was noted, both within and across many of the investigations. One of the more robust findings was that individuals tended to produce shorter utterances when they used graphic symbol-based AAC systems than would be expected, based on participant profiles; however, there appeared to be a developmental trend toward using longer utterances. There has been a dearth of research pertaining to the development and evaluation of appropriate assessment tools and intervention techniques to enhance grammar acquisition for individuals who use AAC. Considerations for developing such tools and techniques are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18465366     DOI: 10.1080/07434610701830587

Source DB:  PubMed          Journal:  Augment Altern Commun        ISSN: 0743-4618            Impact factor:   2.214


  12 in total

1.  Error patterns and revisions in the graphic symbol utterances of 3- and 4-year-old children who need augmentative and alternative communication.

Authors:  Cathy Binger; Kaethe Richter; Allyson Taylor; Emily K Williams; Ashley Willman
Journal:  Augment Altern Commun       Date:  2019-02-26       Impact factor: 2.214

2.  Eye tracking research to answer questions about augmentative and alternative communication assessment and intervention.

Authors:  Krista M Wilkinson; Teresa Mitchell
Journal:  Augment Altern Commun       Date:  2014-04-23       Impact factor: 2.214

3.  Using dynamic assessment to evaluate the expressive syntax of children who use augmentative and alternative communication.

Authors:  Marika R King; Cathy Binger; Jennifer Kent-Walsh
Journal:  Augment Altern Commun       Date:  2015-01-26       Impact factor: 2.214

4.  Tracking Early Sentence-Building Progress in Graphic Symbol Communication.

Authors:  Cathy Binger; Jennifer Kent-Walsh; Nancy Harrington; Quinn C Hollerbach
Journal:  Lang Speech Hear Serv Sch       Date:  2020-04-07       Impact factor: 2.983

5.  The emergence of clause construction in children who use speech generating devices.

Authors:  Gat Savaldi-Harussi; Lyle Lustigman; Gloria Soto
Journal:  Augment Altern Commun       Date:  2019-05-09       Impact factor: 2.214

6.  Conversation-based intervention for adolescents using augmentative and alternative communication.

Authors:  Gloria Soto; Michael T Clarke
Journal:  Augment Altern Commun       Date:  2018-07-25       Impact factor: 2.214

7.  Effects of a Conversation-Based Intervention on the Linguistic Skills of Children With Motor Speech Disorders Who Use Augmentative and Alternative Communication.

Authors:  Gloria Soto; Michael T Clarke
Journal:  J Speech Lang Hear Res       Date:  2017-07-12       Impact factor: 2.297

Review 8.  Interventions for childhood apraxia of speech.

Authors:  Angela T Morgan; Elizabeth Murray; Frederique J Liégeois
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

9.  Speech-generating devices: effectiveness of interface design-a comparative study of autism spectrum disorders.

Authors:  Chien-Hsu Chen; Chuan-Po Wang; I-Jui Lee; Chris Chun-Chin Su
Journal:  Springerplus       Date:  2016-09-29

10.  Finding the best fit: examining the decision-making of augmentative and alternative communication professionals in the UK using a discrete choice experiment.

Authors:  Edward J D Webb; Yvonne Lynch; David Meads; Simon Judge; Nicola Randall; Juliet Goldbart; Stuart Meredith; Liz Moulam; Stephane Hess; Janice Murray
Journal:  BMJ Open       Date:  2019-12-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.